Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Chan Cheah, D. Chihara, S. Horowitz, A. Sevin, Y. Oki, S. Zhou, N.H. Fowler, J.E. Romaguera, F. Turturro, F.B. Hagemeister, L.E. Fayad, M. Wang, S.S. Neelapu, L.J. Nastoupil, J.R. Westin, M.A. Rodriguez, F. Samaniego, P. Anderlini, Y. Nieto, M.A. Fanale

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Agricultural and Biological Sciences